Search

Your search keyword '"Chung, B.I."' showing total 27 results
Start Over Author "Chung, B.I."
27 results on '"Chung, B.I."'

1. The impact of venous thromboembolism on bladder cancer patients undergoing open or minimally-invasive radical cystectomy in the United States: Perioperative outcomes and health-care costs from insurance claims data

Author

Del Giudice, F., primary, Tresh, A., additional, Basran, S., additional, Belladelli, F., additional, De Berardinis, E., additional, Asero, V., additional, Scornajenghi, C.M., additional, Carino, D., additional, Ferro, M., additional, Busetto, G.M., additional, Crocetto, F., additional, Balsamo, R., additional, Barone, B., additional, Pradere, B., additional, Krajewski, W., additional, Nowak, L., additional, Szydełko, T., additional, Moschini, M., additional, Mari, A., additional, Rane, A., additional, Challacombe, B., additional, Nair, R., additional, and Chung, B.I., additional

Published
2024
Full Text
View/download PDF

2. Progression-free survival as surrogate endpoint in high-risk non-muscle invasive bladder cancer studies: results from a machine learning-based analysis of a large multi-institutional database

Author

Marchioni, M., primary, Porreca, A., additional, Di Nicola, M., additional, Lucarelli, G., additional, Dorin, V.M., additional, Soria, F., additional, Terracciano, D., additional, Mistretta, F.A., additional, Buonerba, C., additional, Cantiello, F., additional, Mari, A., additional, Minervini, A., additional, Veccia, A., additional, Musi, G., additional, Hurle, R., additional, Busetto, G.M., additional, Del Giudice, F., additional, Chung, B.I., additional, Berardinelli, F., additional, Perdonà, S., additional, Del Prete, P., additional, Mirone, V., additional, Borghesi, M., additional, Bove, P., additional, Autorino, R., additional, Crisan, N., additional, Battaglia, M., additional, Ditonno, P., additional, Russo, G.I., additional, Muto, M., additional, Damiano, R., additional, Porpiglia, F., additional, de Cobelli, O., additional, Schips, L., additional, and Ferro, M., additional

Published
2022
Full Text
View/download PDF

4. Contemporary trends of systemic neoadjuvant and adjuvant intravesical chemotherapy in patients with upper tract urothelial carcinomas undergoing minimally invasive or open radical nephroureterectomy: analysis of us claims on perioperative outcomes and health care costs

Author

Del Giudice, F., primary, Chung, B.I., additional, Maggi, M., additional, Sciarra, A., additional, Salciccia, S., additional, Scornajenghi, C.M., additional, Asero, V., additional, and De Berardinis, E., additional

Published
2022
Full Text
View/download PDF

5. Compared efficacy of adjuvant intravesical BCG-TICE vs. BCG-RIVM for high-risk non-muscle invasive bladder cancer (NMIBC): a propensity score matched analysis

Author

Del Giudice, F., primary, Flammia, R.S., additional, Chung, B.I., additional, Maggi, M., additional, Sciarra, A., additional, Scornajenghi, C.M., additional, Asero, V., additional, Pandolfo, S.D., additional, Falagario, U.G., additional, D’Attila, N., additional, Mancini, V., additional, Chirico, M., additional, Cinelli, F., additional, Carrieri, G., additional, De Berardinis, E., additional, and Busetto, G.M., additional

Published
2022
Full Text
View/download PDF

6. Contemporary trends of systemic neoadjuvant and adjuvant intravesical chemotherapy for upper tract urothelial carcinomas undergoing minimally invasive or open radical nephroureterectomy: US-claims analysis on perioperative and health care costs outcomes

Author

Del Giudice, F., primary, Stefanie, V.U., additional, Sciarra, A., additional, Salciccia, S., additional, Maggi, M., additional, Canale, V., additional, Flammia, S., additional, Viscuso, P., additional, Moriconi, M., additional, Pecoraro, M., additional, Panebianco, V., additional, and Chung, B.I., additional

Published
2022
Full Text
View/download PDF

7. The influence of operative time and blood loss on surgical margins and functional outcomes at laparoscopic versus robotic-assisted radical prostatectomy: A prospective multicenter study

Author

Maggi, M., primary, Rosati, D., additional, Viscuso, P., additional, Canale, V., additional, Frisenda, M., additional, Catuzzi, R., additional, Moriconi, M., additional, Asero, V., additional, Scarrone, E., additional, Carbone, A., additional, Pastore, A.L., additional, Fuschi, A., additional, Di Pierro, G.B., additional, Busetto, G.M., additional, De Berardinis, E., additional, Ricciuti, G.P., additional, Panebianco, V., additional, Magliocca, F.M., additional, Del Giudice, F., additional, Chung, B.I., additional, Sciarra, A., additional, and Salciccia, S., additional

Published
2022
Full Text
View/download PDF

8. Compared Efficacy of Adjuvant Intravesical BCG TICE vs. RIVM for High-risk Non-muscle Invasive Bladder Cancer: A Multicenter Propensity Score Matched Analysis

Author

Del Giudice, F., primary, Flammia, S., additional, Sciarra, A., additional, Salciccia, S., additional, Maggi, M., additional, Canale, V., additional, Viscuso, P., additional, Moriconi, M., additional, Busetto, G.M., additional, Falagario, U., additional, Carrieri, G., additional, Cormio, L., additional, Skinner, E.C., additional, Chung, B.I., additional, and De Berardinis, E., additional

Published
2022
Full Text
View/download PDF

13. SC221 - Progression-free survival as surrogate endpoint in high-risk non-muscle invasive bladder cancer studies: results from a machine learning-based analysis of a large multi-institutional database

Author

Marchioni, M., Porreca, A., Di Nicola, M., Lucarelli, G., Dorin, V.M., Soria, F., Terracciano, D., Mistretta, F.A., Buonerba, C., Cantiello, F., Mari, A., Minervini, A., Veccia, A., Musi, G., Hurle, R., Busetto, G.M., Del Giudice, F., Chung, B.I., Berardinelli, F., Perdonà, S., Del Prete, P., Mirone, V., Borghesi, M., Bove, P., Autorino, R., Crisan, N., Battaglia, M., Ditonno, P., Russo, G.I., Muto, M., Damiano, R., Porpiglia, F., de Cobelli, O., Schips, L., and Ferro, M.

Published
2022
Full Text
View/download PDF

15. A1167 - The influence of operative time and blood loss on surgical margins and functional outcomes at laparoscopic versus robotic-assisted radical prostatectomy: A prospective multicenter study

Author

Maggi, M., Rosati, D., Viscuso, P., Canale, V., Frisenda, M., Catuzzi, R., Moriconi, M., Asero, V., Scarrone, E., Carbone, A., Pastore, A.L., Fuschi, A., Di Pierro, G.B., Busetto, G.M., De Berardinis, E., Ricciuti, G.P., Panebianco, V., Magliocca, F.M., Del Giudice, F., Chung, B.I., Sciarra, A., and Salciccia, S.

Published
2022
Full Text
View/download PDF

19. A0163 - Compared Efficacy of Adjuvant Intravesical BCG TICE vs. RIVM for High-risk Non-muscle Invasive Bladder Cancer: A Multicenter Propensity Score Matched Analysis.

Author

Del Giudice, F., Flammia, S., Sciarra, A., Salciccia, S., Maggi, M., Canale, V., Viscuso, P., Moriconi, M., Busetto, G.M., Falagario, U., Carrieri, G., Cormio, L., Skinner, E.C., Chung, B.I., and De Berardinis, E.

Subjects
*PROPENSITY score matching, *CANCER invasiveness, *BLADDER cancer, *UROTHELIUM
Published
2022
Full Text
View/download PDF

20. A1064 - Diagnostic performance of Node-RADS by preoperative CT or MRI scans for prediction of pathological Nodal (pN) status from Muscle-Invasive Bladder Cancers (MIBCs) undergoing Radical Cystectomy (RC) with extended Pelvic Lymph-node Dissection (ePLND)

Author

Del Giudice, F., Flammia, S., Pecoraro, M., Bicchetti, M., Lucciola, S., Chung, B.I., Bucca, B., Proietti, F., Licari, L.C., Bologna, E., Asero, V., Scornajenghi, C.M., De Berardinis, E., Sciarra, A., Catalano, C., Panebianco, V., and Leonardo, C.

Subjects
*CANCER invasiveness, *COMPUTED tomography, *BLADDER cancer, *CYSTECTOMY, *DISSECTION
Published
2023
Full Text
View/download PDF

22. A0279 - Progression-free survival as surrogate endpoint in high-risk non-muscle invasive bladder cancer studies: Results from a machine learning-based analysis of a large multi-institutional database.

Author

Marchioni, M., Porreca, A., Di Nicola, M., Lucarelli, G., Dorin, V.M., Soria, F., Terracciano, D., Mistretta, F.A., Buonerba, C., Cantiello, F., Mari, A., Minervini, A., Veccia, A., Antonelli, A., Musi, G., Hurle, R., Busetto, G.M., Del Giudice, F., Chung, B.I., and Berardinelli, F.

Subjects
*NON-muscle invasive bladder cancer, *PROGRESSION-free survival, *DATABASES
Published
2023
Full Text
View/download PDF

23. A0827 - Time for Double-J (DJ) indwelling ureteral stent removal following primary or salvage pyeloplasty in US adult patients is affected by demographic and perioperative factors: Results from a large population-based cohort analysis.

Author

Del Giudice, F., Asero, V., Salcicci, S., Li, S., Belladelli, F., Sciarra, A., Scornajenghi, C.M., Bologna, E., De Berardinis, E., Basran, S., and Chung, B.I.

Subjects
*SURGICAL stents, *COHORT analysis, *ADULTS
Published
2023
Full Text
View/download PDF

24. A0774 - Contemporary trends in the surgical management of stress urinary incontinence after radical prostatectomy in the united states: Insurance claim data on socio-demographic/ surgical predictors and differential average costs analysis.

Author

Del Giudice, F., Basran, S., Li, S., Belladelli, F., Sciarra, A., Salciccia, S., Asero, V., Scornajenghi, C.M., Bologna, E., De Berardinis, E., and Chung, B.I.

Subjects
*URINARY stress incontinence, *RADICAL prostatectomy, *STRESS management, *INSURANCE claims, *COST analysis, *RETROPUBIC prostatectomy
Published
2023
Full Text
View/download PDF

25. A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques

Author

Nicola d’Altilia, Vito Mancini, Ugo Giovanni Falagario, Leonardo Martino, Michele Di Nauta, Beppe Calò, Francesco Del Giudice, Satvir Basran, Benjamin I. Chung, Angelo Porreca, Lorenzo Bianchi, Riccardo Schiavina, Eugenio Brunocilla, Gian Maria Busetto, Carlo Bettocchi, Pasquale Annese, Luigi Cormio, Giuseppe Carrieri, d'Altilia N., Mancini V., Falagario U.G., Martino L., Di Nauta M., Calo B., Del Giudice F., Basran S., Chung B.I., Porreca A., Bianchi L., Schiavina R., Brunocilla E., Busetto G.M., Bettocchi C., Annese P., Cormio L., and Carrieri G.

Subjects
Cancer Research, prostate cancer, male incontinence, robotic prostatectomy, Oncology
Abstract

Background: Radical prostatectomy is considered the gold-standard treatment for patients with localized prostate cancer. The literature suggests there is no difference in oncological and functional outcomes between robotic-assisted radical prostatectomy (RARP) and open (RRP). (2) Methods: The aim of this study was to compare continence recovery rates after RARP and RRP measured with 24 h pad weights and the International Consultation on Incontinence Questionnaire—Short Form (ICIQ-SF). After matching the population (1:1), 482 met the inclusion criteria, 241 patients per group. Continent patients with a 24 h pad test showing 200 g of urinary leakage. (3) Results: There was no difference between preoperative data. As for urinary continence (UC) and incontinence (UI) rates, RARP performed significantly better than RRP based on objective and subjective results at all evaluations. Univariable and multivariable Cox Regression Analysis pointed out that the only significant predictors of continence rates were the bilateral nerve sparing technique (1.25 (CI 1.02,1.54), p = 0.03) and the robotic surgical approach (1.42 (CI 1.18,1.69) p ≤ 0.001). (4) Conclusions: The literature reports different incidences of UC depending on assessment and definition of continence “without pads” or “social continence” based on number of used pads per day. In this, our first evaluation, the advantage of objective measurement through the weight of the 24 h and subjective measurement with the ICIQ-SF questionnaire best demonstrates the difference between the two surgical techniques by enhancing the use of robotic surgery over traditional surgery.

Published
2022

26. Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study

Author

Angelo Porreca, Marco Giampaoli, Matteo Ferro, Benjamin I. Chung, Daniele D'Agostino, Francesco Del Giudice, Riccardo Schiavina, Ottavio De Cobelli, Giuseppe Lucarelli, Paolo Corsi, Gian Maria Busetto, Daniele Romagnoli, Alessandro Sciarra, Martina Maggi, Ettore De Berardinis, Alessandro Del Rosso, Porreca A., Del Giudice F., Giampaoli M., D'Agostino D., Romagnoli D., Corsi P., Del Rosso A., Maggi M., Chung B.I., Ferro M., de Cobelli O., Lucarelli G., Schiavina R., De Berardinis E., Sciarra A., and Busetto G.M.

Subjects
Image-Guided Biopsy, Male, medicine.medical_specialty, detection rate, Prostate biopsy, Urology, Observational Study, Single Center, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Prostate, Biopsy, medicine, Humans, biopsy, 030212 general & internal medicine, prostate biopsy, Prospective Studies, Prospective cohort study, Watchful Waiting, Aged, Ultrasonography, medicine.diagnostic_test, business.industry, clinically significant, Prostatic Neoplasms, General Medicine, Middle Aged, medicine.disease, prostate cancer, Magnetic Resonance Imaging, Prospective Studie, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Cohort, Prostatic Neoplasm, business, magnetic resonance imaging, Research Article, Human
Abstract

Magnetic resonance imaging (MRI) targeted biopsy (TBx) of the prostate demonstrated to improve detection rate (DR) of clinically significant prostate cancer (csPCa) in biopsy-naive patients achieving strong level of evidence. Nevertheless, the csPCa yield for TBx alone versus TBx plus systematic biopsy (SBx) after accounting for overlapping of SBx cores with TBx cores, in prior-negative or active surveillance (AS) patients has not been well established. The objective of the study was to investigate benefits in terms of detection rate and pathological stratification of prostate cancer (PCa) using contextual SBx during MRI-TBx. Patients previously submitted to negative-SBx (cohort A) and those enrolled in an AS program (cohort B) who showed at least 1 suspicious area with a PIRADSv2 score ≥ 3 were prospectively and randomly assigned to only TBx strategy versus TBx plus SBx strategy. SBx locations could not encompass the TBx sites, so that the results of each type of biopsy were independent and did not overlap. A total of 312 patients were included in the 2 cohorts (cohort A: 213 cases; cohort B: 99 cases). No significant differences were found in terms of overall PCa-DR (77.6% vs 69.6% respectively; P = .36) and csPCa-DR (48.2% vs 60.9 respectively; P = .12). The MRI-TBx alone cohort showed higher csPCa/PCa ratio (87.5% vs 62.2%; P = .03). The MRI-TBx plus SBx group subanalysis showed significantly higher csPCa-DR obtained at the MRI-TBx cores when compared with the SBx cores (43.7% vs 24.1%, respectively; P = .01). Independently to age, prostatic-specific antigen and prostate imaging-reporting and data system score, either in rebiopsy (OR 0.43, 0.21–0.97) or AS (OR 0.46, 0.32–0.89) setting, SBx cores were negatively associated with the csPCa-DR when combined to TBx cores. MRI-TBx should be considered the elective method to perform prostate biopsy in patients with previous negative SBx and those considered for an AS program. Adding SBx samples to MRI-TBx did not improve detection rate of csPCa.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results